Clinical trials
Recruiting Phase 1/2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 84 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 6 |
| GI Innovation, Inc. | 3 |
| Artios Pharma Ltd | 2 |
| Avenzo Therapeutics, Inc. | 2 |
| Essen Biotech | 2 |
| Ipsen | 2 |
| M.D. Anderson Cancer Center | 2 |
| Nuvalent Inc. | 2 |
| Revolution Medicines, Inc. | 2 |
| Shenzhen Ionova Life Sciences Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 84 |
| Carcinoma, Non-Small-Cell Lung | 22 |
| Colorectal Neoplasms | 19 |
| Pancreatic Neoplasms | 17 |
| Neoplasms | 16 |
| Melanoma | 15 |
| Breast Neoplasms | 14 |
| Endometrial Neoplasms | 13 |
| Lung Neoplasms | 12 |
| Ovarian Neoplasms | 12 |
Trials
Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.